The use of triple therapy to minimize cyclosporine (CsA) nephrotoxicity in renal transplantation.
Landsberg
D N
DN
Department of Medicine, St. Paul's Hospital University of British Columbia, Vancouver, Canada.
Rae
A
A
Chiu
A
A
Werb
R
R
Taylor
P
P
Chan-Yan
C
C
Manson
A D
AD
D000328:Adult; D000368:Aged; D001379:Azathioprine / Q000627:therapeutic use*; D003404:Creatinine / Q000097:blood; D003524:Cyclosporins / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006085:Graft Survival; D006801:Humans; D007668:Kidney / Q000187:drug effects / Q000473:pathology; D016030:Kidney Transplantation; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use*; D011379:Prognosis
D003524:Cyclosporins; D003404:Creatinine; D001379:Azathioprine; D011241:Prednisone